Measuring stability to more effectively select therapeutic antibody candidates

This therapeutic antibody drug development webinar, discusses the idea of limiting the substantial investment of time, money, or resources. If you choose the right analytical tools to help make smarter decisions. We highlight why our Prometheus instrument using nanoDSF technology will help to make quantitative, data-driven solutions to help accelerate the therapeutic antibody drug development. Have a listen if you’re a curious scientist who loves learning about new technologies and how they can help make research more efficient!

Previous Video
Happy proteins make happy researchers, and how Tycho helps with that
Happy proteins make happy researchers, and how Tycho helps with that

How do you usually know whether your protein is happy? Even if you’re already using a portfolio of techniqu...

Up next
Tackle small molecule drug discovery screening challenges with Dianthus
Tackle small molecule drug discovery screening challenges with Dianthus

A big hurdle in small molecule drug discovery screening is confidently identifying positive hits in a timel...